Bremer Trust National Association’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$250K Sell
4,006
-650
-14% -$45.4K 0.05% 228
2018
Q3
$359K Sell
4,656
-1,550
-25% -$117K 0.09% 190
2018
Q2
$440K Sell
6,206
-6,727
-52% -$475K 0.12% 172
2018
Q1
$975K Buy
12,933
+2,245
+21% +$178K 0.28% 97
2017
Q4
$766K Buy
10,688
+3,386
+46% +$257K 0.21% 112
2017
Q3
$592K Buy
7,302
+1,146
+19% +$87.6K 0.16% 131
2017
Q2
$435K Sell
6,156
-3,389
-36% -$226K 0.12% 154
2017
Q1
$648K Sell
9,545
-6,685
-41% -$470K 0.18% 130
2016
Q4
$1.16M Sell
16,230
-22,998
-59% -$1.71M 0.32% 88
2016
Q3
$3.1M Sell
39,228
-11,425
-23% -$928K 0.84% 27
2016
Q2
$4.22M Sell
50,653
-2,357
-4% -$209K 1.17% 21
2016
Q1
$4.87M Sell
53,010
-1,214
-2% -$109K 1.4% 13
2015
Q4
$5.49M Buy
54,224
+36,399
+204% +$3.79M 1.64% 9
2015
Q3
$1.75M Buy
17,825
+614
+4% +$68.2K 0.57% 55
2015
Q2
$2.02M Buy
17,211
+1,590
+10% +$174K 0.6% 51
2015
Q1
$1.53M Buy
15,621
+200
+1% +$20.3K 0.49% 55
2014
Q4
$1.45M Buy
15,421
+364
+2% +$37.6K 0.47% 57
2014
Q3
$1.6M Buy
15,057
+201
+1% +$19.7K 0.54% 49
2014
Q2
$1.23M Buy
14,856
+208
+1% +$16.2K 0.43% 56
2014
Q1
$1.04M Buy
14,648
+1,855
+15% +$145K 0.38% 63
2013
Q4
$961K Buy
12,793
+655
+5% +$45.6K 0.36% 64
2013
Q3
$763K Buy
12,138
+3,243
+36% +$194K 0.32% 74
2013
Q2
$456K Buy
+8,895
New +$464K 0.2% 107

Other funds holding GILD

Bremer Trust National Association's GILD Position: Q4 2018 in Review

Bremer Trust National Association reduced its Gilead Sciences (GILD) stake by 14% in Q4 2018, selling an estimated $45.4K and leaving 4,006 shares worth $250K. The position accounts for 0.05% of the portfolio, ranked #228.

Bremer Trust National Association first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $5.49M in Q4 2015. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Bremer Trust National Association held 4,006 shares of Gilead Sciences worth $250K as of Q4 2018.
  • Bremer Trust National Association sold 650 Gilead Sciences shares in Q4 2018, an estimated $45.4K.
  • Gilead Sciences made up 0.05% of Bremer Trust National Association's portfolio in Q4 2018, its #228 holding.
  • Bremer Trust National Association first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • Bremer Trust National Association's Gilead Sciences position peaked at $5.49M in Q4 2015.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.